Abstract
Introduction
Defects in vesicular trafficking in both the synthetic and degradative pathways have been recently recognized as an important cell biological mechanism in various human diseases, including cancer, a variety of neurological disorders and autoimmune diseases [1, 2] . Disorders related to defects of vesicular acidification in kidney include Dent disease, some other forms of Fanconi's syndrome, as well as nephropathy during diabetes and polycystic kidney disease [3, 4] . Vesicle acidification has long been known to be important for receptor-ligand dissociation in endosomes [5] and activation of hydrolytic enzymes in lysosomes [6] [7] [8] . However, it was unknown how acidification regulates other key intracellular trafficking events including the budding, coating and potentially fusion of intracellular carrier vesicles. Moreover, the cell biological mechanisms by which intravesicular pH information is transmitted to cytosolic regulatory proteins (including small GTPases) that control and direct these vesicular apical plasma membrane proteins [12] . Many low-molecularmass plasma proteins as well as many drugs are reabsorbed in the PT by receptor-mediated endocytosis and are delivered to lysosomes for degradation ( Figure 1A ). This process involves two apically located multiligand-binding receptors, megalin and cubilin [13, 14] . Similarly to other eukaryotic cells, the acidification of PT endosomes and lysosomes is driven by the V-ATPase [3, 4, 15] . This electrogenic pump translocates protons from the cytoplasm to the organellar lumen, which in conjunction with a parallel chloride conductance (CLC-5 and CLC-4 electrogenic Cl − /H + -exchangers) generates the acidic milieu (pH between 5.0 and 6.0) of the endosomal/lysosomal compartments [16] [17] [18] . Perturbation of endosomal acidification in PT cells leads to pathophysiological dysfunction typified by diminished reabsorption and urinary wasting of albumin and other low-molecular-mass proteins [3] . The physiological importance of endosomal acidification is also underlined by our recent finding that the V-ATPase inhibitors (bafilomycin and concanamycin) as well as acidification uncouplers [NH 4 Cl and FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone)] strongly abolish albumin uptake by MTCs (mouse proximal tubule cells) ( Figure 1B ) [9] . Moreover, a mutation in CLC-5 results in Dent disease, whose manifestations include Fanconi's syndrome in humans, which is accompanied by deficient protein reabsorption and proteinuria [19, 20] . CLC-5-knockout mice have similar defects in the PT endosomal/lysosomal protein degradative pathway [16] [17] [18] 21, 22] . However, the biochemical mechanism linking deficient endosomal acidification and impaired function of this degradative pathway was poorly understood. Recent results from our laboratory have provided new insights into this process by showing a direct involvement of the endosomal V-ATPase in acidification-dependent transmembrane signalling that involves a direct interaction with cytosolic small GTPases that regulate vesicular trafficking.
Arf-family small GTPases and their GEFs
The Arfs comprise a family of small GTPases that play a central role in the regulation of many vesicular transport processes in eukaryotic cells [23] . These small GTPases are critical for the regulation of vesicular trafficking both in exo-and endo-cytosis pathways. For example, Arf1 is involved in regulating ER (endoplasmic reticulum)-Golgi trafficking [24, 25] , whereas Arf6 is involved in the regulation of endocytosis [26] . In particular, Arf6 has been implicated in endocytosis by regulating: (i) actin cytoskeleton remodelling [27] ; (ii) lipid modifications and rearrangements [28] ; and (iii) carrier vesicle coat formation [29, 30] . While the role of Arf1 in COPI (coatamer protein I) coat recruitment has been well documented, the role of Arf6 in this process is just emerging. These studies indicate that Arf6 is involved in the formation of both clathrin carrier vesicles that are derived from the plasma membrane [29] and carrier vesicles that are derived from endosomes [30] . The activation of Arfs is catalysed by GEFs, which constitute a large and diverse family [31] . The multiplicity of Arfs (6 members) and Arf-GEFs (49 members) suggests that different GEFs have substrate preference towards specific Arfs; for example, ARNO (Arf nucleotide site opener) preferentially activates Arf6 [32] . Thus both regulation of specific activities and targeting of Arf isoforms to different intracellular membranes are most likely to be achieved through selective sets of GEFs that are associated with target membranes, including organelles (endosomes and lysosomes) of the protein degradative pathway ( Figure 1A) .
Previously, work from Schulz and co-workers [33, 34] reported a pH-dependent interaction of Arf small GTPases with purified pancreatic microsomal vesicles. However, the specific members of the Arf family that are involved in this recruitment were not established because pan-Arf antibodies were used in these studies. Moreover, the specific compartment in which this interaction occurs and the molecular mechanism of pH-dependent Arf recruitment remained obscure. Subsequent studies from Gruenberg and co-workers demonstrated acidification-dependent recruitment of β-COP and -COP coat proteins [35, 36] as well as Arf1 [37] on to early endosomes purified from BHK (baby-hamster kidney) cells. They proposed that a hypothetical PSP (pH-sensing protein) is involved in interaction with β-COP and that this biochemical event is necessary for the formation of transport carrier vesicles from early endosomes [35] [36] [37] . While the existence of an endosomal PSP was suggested, its nature and pH-sensing molecular mechanism remained unknown.
Recently, we demonstrated that in PT epithelial cells, Arf6 is targeted to apical vesicles of the degradative pathway, where it co-localized with V-ATPase on early endosomes [38] . Localization of Arf6 in the kidney is cell-specific, since in collecting duct epithelial cells this small GTPase is targeted to basolateral vesicles [39] . Interestingly, Arf1 is targeted both to the trans-Golgi network and to the apical pole of PT cells in situ where it co-localizes with megalin, but its role in function of this receptor is unknown. We also reported the expression and targeting of ARNO to PT early endosomes. Similarly to Arf6, this protein also co-localized with the endosomal V-ATPase [38] . Moreover, specific recruitment of both ARNO and Arf6 (but not Arf1) from the cytosol to endosomal membranes depends on V-ATPase-driven intra-endosomal acidification, implicating this event in regulation of the endosomal/lysosomal protein degradative pathway. The existence of a PSP and its direct and specific interaction with ARNO and/or Arf6 were also proposed in this study [38] , but the nature of the PSP and the mechanism of its pH-dependent interaction with small GTPases still remained elusive.
Structure, function and regulation of the V-ATPase
The V-ATPase is a large multimeric complex comprised of a transmembrane V 0 -sector and a cytoplasmic V 1 -sector [4, 15] . The structure and subunit composition of yeast and mammalian V-ATPases are very similar, reflecting high degree of homology between both enzymes. Previously, a new revised nomenclature for each subunit of mammalian VATPase was proposed [40] . The cytoplasmic V 1 -sector is a 600-650 kDa complex composed of eight different subunits (A-H) of molecular masses 70-13 kDa that is responsible for ATP hydrolysis. The transmembrane V 0 -sector is a 260 kDa complex composed of six different subunits (a, c, c , c , d and e) of molecular masses 100-9 kDa that is responsible for proton translocation [4, 15] . In mouse, four isoforms of a-subunit (a1, a2, a3 and a4) have been identified by the Futai [41, 42] , Forgac [43] and Karet [44] laboratories. The mammalian VATPase a-subunit is a ∼100 kDa transmembrane protein that is homologous with yeast Vph1p/Stv1p [45] . This subunit contains two dissimilar parts: (i) an N-terminal hydrophilic part (a2N), a tail of ∼400 amino acids located on the cytosolic side of the membrane; and (ii) a C-terminal hydrophobic part containing six to nine putative TMs (transmembrane helices) (Figures 2 and 3) . While the size of a2N tail and its cytosolic orientation is generally accepted, the transmembrane topology (number of TMs, as well as size, location of its loops and C-terminal tail) (Figures 2 and 3 ) of this protein is a controversial issue and will be discussed below.
Increasing evidence over the last decade has shown that the V-ATPase has the capacity to bind to numerous regulatory proteins. It, therefore, appears that the cascade of events that ultimately modulate the V-ATPase (assembly, targeting and activity) and subsequent intravesicular acidification might be controlled at different levels via protein-protein interactions. Previous studies demonstrated a direct interaction of VATPase with SNARE (soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor) proteins [46] and with the actin cytoskeleton [47] . Both the B-and C-subunits of the V 1 -sector of V-ATPase have been shown to bind actin. Work from the Breton laboratory [48] has shown that a Cterminal DTAL motif on the B 1 -subunit is involved in binding of the V-ATPase to actin via the PDZ protein NHERF (Na + /H + -exchanger regulatory factor) [48] . An important regulatory mechanism for modulation of V-ATPase function and activity is by disassembly/assembly of the V 0 -and V 1 -sectors of the enzyme. This reversible disassembly/assembly of V-ATPase is regulated by glucose in yeast [49] , the larval insect midgut [50] and renal epithelial [51] cells. Moreover, physical interaction between glycolytic enzyme aldolase and V-ATPase is essential for the assembly and activity of the proton pump [52] . Glucose-dependent assembly/disassembly of V-ATPase is also modulated by acidification of vacuoles and thus the presence of a pH-sensor protein was recently suggested in yeast vacuoles [53] . Finally, the regulation of V-ATPase activity by more efficient recruitment of the V 0 -and V 1 -sectors on to lysosomal membranes has also been demonstrated during maturation of mammalian dendritic cells [6] . This mechanism is critical for lysosomal acidification, activation of proteases and efficient protein degradation [54] .
The V-ATPase a2-subunit as a putative endosomal pH-sensor Previously, we [4, 9, 15, 38] and others [35] [36] [37] have proposed that intravesicular acidification not only provides an optimal pH inside organelles, but due to the presence of one or more unknown hypothetical PSP(s) also represents a signalling mechanism that modulates the recruitment of cytosolic proteins to the vesicle membrane. In our search for this protein, we recently examined the role of endosomal acidification on megalin/cubilin-mediated albumin-Alexa [9]. These experiments were designed as follows (Figure 1B) : (i) transfection and labelling of late endosomes with Rab7-EGFP (enhanced green fluorescent protein); (ii) pulse with fluorescent albumin-Alexa Fluor R 594 ligand;
and (iii) real-time chase of its trafficking using the spinning disc confocal microscopy. These experiments demonstrated that, in control MTCs, albumin-Alexa Fluor R 594 is delivered from the plasma membrane to early endosomes (red vesicles) during 5-15 min (see Supplementary Figure S1A and Movie S1, part 1, at http://www.biochemsoctrans. org/bst/035/bst0351092add.htm) and reached Rab7-EGFPlabelled late endosomes (yellow vesicles) after 70 min of chase (see Supplementary Figure S1B and Movie S1, part 2). We found that inhibition of V-ATPase-driven endosomal acidification by bafilomycin does not affect initial ligand internalization or trafficking through the recycling pathway, but selectively affects the degradative pathway by preventing the delivery of albumin-Alexa Fluor R 594 from early to late endosomes (see Supplementary Figure S1C and Movie S2 at http://www.biochemsoctrans.org/bst/035/bst0351092add.htm). This leads to accumulation of cargo in early endosomes and, ultimately, to inhibition of endocytosis. We also show that the a2-isoform of V-ATPase is specifically targeted to and co-localize with EEA1 (early endosome antigen 1) in early endosomes (see Supplementary Figure S2 and Movie S3 at http://www.biochemsoctrans.org/bst/035/ bst0351092add.htm). Importantly, the transmembrane a2-isoform directly interacts with cytosolic ARNO via its Nterminal (a2N) cytosolic tail (Figures 2 and 3 ) and this interaction is modulated by acidification of the endosomal lumen. This interaction is specific, as Arf6 does not bind to the a2-isoform but, instead, interacts with the c-subunit. Interaction between Arf6 and the c-subunit is also specific, as binding of the c-subunit with Arf1 was not detectable [9] .
These results led us to propose that the V-ATPase itself might be the long-sought PSP. According to this model, the V-ATPase is a multifunctional complex that is responsible for: (i) the generation of a pH gradient across the vesicular membrane; (ii) sensing and/or measuring of intravesicular pH; and (iii) subsequently transmitting this information from the vesicle lumen to the cytosolic side of the membrane. It is generally accepted that transmembrane signalling is a common phenomenon that regulates a variety of cellular processes, most notably receptor-ligand-induced cascades. The V-ATPase as a pH-sensor would, therefore, add pH to the growing list of signals that can be transmitted from one side of a biological membrane to the other. This function of V-ATPase may extend to acidic organelles in general and provides a new concept in cell biology, with possible important implications in physiology and medicine.
Proposed role of histidine residues in the function and cell biology of PSPs
In eukaryotic cells, the receptor-mediated endocytosis pathway (Figure 1 ) is also used to internalize and process macromolecules such as toxins, RNA and DNA. This pathway also provides an entry for mammalian viruses and the infection process requires a V-ATPase-driven acidic endosomal environment [55] . The membrane fusion of vesicular-stomatitis virus depends on endosomal acidification and involves conformational changes due to protonation of histidine residues [56] . Recently, the crucial role of histidine residues in the function of the hydrogen ion channel of the M2-protein from influenza A virus has been demonstrated [57] . The pH-dependent conformational flexibility of the SARS (severe acute respiratory syndrome) coronavirus proteinase also depends on two critical histidine residues in its substrate-binding site [58] . Among the bestcharacterized eukaryotic proteins with pH-sensing capability are the hisactophilins, actin and lipid binding proteins of Dictyostelium discoideum [59] . These proteins, which have a high content of 31-35 histidine residues clustered in loops on the surface of the molecules, efficiently associate with actins or lipids only at pH <6.5, but not at pH 7.5 [60] . To date, several other mammalian transmembrane proteins have been identified as having pH-sensing capability during their function [61] [62] [63] [64] [65] [66] [67] . Histidine residues in all of these proteins have been identified as crucial components of their pH-sensing mechanism. For example, OGR1 (ovarian cancer G-protein-coupled receptor 1) was proposed to function as a proton-sensing receptor involved in blood pH homoeostasis [67] . Site-directed mutagenesis shows that histidine residues (His-17, His-20, His-84 and His-269) at the extracellular surface are involved in the pH-sensing mechanism and are required for normal pH-sensitivity of this receptor.
Molecular mechanism by which the V-ATPase a2-subunit functions as a putative endosomal pH-sensor: a hypothesis
We hypothesize here that pH-sensitive amino acid histidine residues in the a2-subunit of V-ATPase could also be involved in the function of the V-ATPase as a pH-sensor. The histidine residues could be a part of a luminal structure that senses the intra-endosomal (intravesicular) pH and transmit this information through conformational changes of this subunit to the cytoplasmic domain of the protein. The mouse a2-subunit contains a total of 21 histidine residues, of which seven residues (His-93, His-130, His-236, His-246, His-248, His-278 and His-310) are located in the a2N cytosolic tail (Figures 2 and 3 , indicated in green) and, thus, are probably not involved in the pH-sensing mechanism. The remaining 14 histidine residues are scattered over the hydrophobic C-terminal part and their transmembrane and/or endosomal lumen (Figures 2 and 3 , indicated in red) versus cytosolic (Figures 2 and 3 , indicated in green) localization depends on the transmembrane topology of V-ATPase a2-subunit. However, the transmembrane topology of mammalian a-isoforms and their yeast orthologues Vph1p/Stv1p is a controversial issue, as discussed below.
Topology models with an 'odd number' (seven or nine) of TMs
Originally, a nine-TM topological model for the mouse a-isoforms was independently proposed by the Futai [41, 42] and Forgac [43] laboratories. Putative TMs were defined either from in silico hydropathy analysis [41, 42] using the 'Kyte-Doolittle' algorithm [68] or from an experimental topographical analysis of yeast Vph1p [69] and its sequence alignment with mouse a-isoforms [43] . A revised model based on cysteine-mutagenesis and chemical modifications has been previously proposed [45] . The model of mouse a2-isoform with nine TMs [41] [42] [43] and the distribution of histidine residues is shown in Figure 2 . In this model, the N-terminal tail (a2N) is located in the cytosol, and the small C-terminal tail (a2C) is in the endosomal lumen. According to this model, the putative pH-sensing histidine residues are located in: (i) LL2 (His-493 and His-511); (ii) LL3 (His-639 and His-647); and (iii) a2C-tail (His-821) (Figure 2, indicated in red) . Histidine residues that form part of the proposed TMs are: (i) TM2 (His-417); (ii) TM4 (His-562 and His-574); (iii) TM7 (His-738); (iv) TM8 (His-763); and (v) TM9 (His-816) and are also indicated in red. Sequence alignment and 'KyteDoolittle' hydropathy analysis of the bovine a2-isoform and mouse a2-isoforms (J6B7, a putative immune regulatory factor) predicted seven TMs [70] . A similar analysis performed with human a2-isoform (hTJ6 is its original nomenclature) also predicted a seven-TM topology [71] . However, the authors did not rule out the possibility that human a2-isoform possesses six, instead of seven transmembrane domains.
Topology models with an 'even number' (6 or 8) of TMs
The human and mouse kidney-specific a4-isoform was previously cloned by the Karet laboratory [44, 72] . In these studies, the hydropathy analysis of both human [72] and mouse [44] a4-isoforms was performed using the 'TMpred' program [73] and, in contrast with the models described above [41] [42] [43] , suggested a model with six TMs [44, 72] . Recently, the alignment and in silico analysis of four mouse aisoforms (a1-a4) with the yeast Vph1p orthologue predicted eight TMs in these proteins [74] . However, the programs and algorithms used in this analysis were not published in this study [74] . This model for the mouse a2-isoform with eight TMs and resulting distribution of histidine residues is shown in Figure 3 [74] . Importantly, according to the six-TM [44, 72] and eight-TM [74] models, both the N-terminal tail (a2N) and the C-terminal tail (a2C) are located in the cytosol (Figure 3 ). These models are supported by experimental results showing the interaction of phosphofructokinase-1 (a cytosolic glycolytic enzyme) with the C-terminal tail of the human a4-and a1-isofroms [75] . It is evident that the location and composition of the cytosolic versus endosomal lumen loops are also dramatically different between the nine-TM (Figure 2 ) and eight-TM (Figure 3 ) models. Finally, according to the eight-TM model, the potential putative pHsensing histidine residues are also different and are located in: (i) LL1 (His-434); (ii) LL2 (His-574 and His-576); and (iii) LL3 (His-639) (Figure 3, indicated in red) . Histidine residues that form part of the predicted TMs: (i) TM1 (His-417); (ii) TM3 (His-562); and (iii) TM7 (His-763) are also indicated in red.
In conclusion, this short review has outlined a proposed role for critical histidine residues in pH-sensing and pH-mediated conformational changes of the endosomal V-ATPase a2-isoform. This novel function is tightly coupled with the more traditional proton pumping activity of the V-ATPase and controls the direct interaction of V-ATPase subunits with small GTPases that, in turn, regulates the endosomal/lysosomal protein degradative pathway [9] . However, in order to test this hypothesis, it is absolutely essential that we increase our understanding of the folding and transmembrane topology of the a-subunit isoforms, which are crucial to the function and regulation of the V-ATPase. This will depend on the application to V-ATPase biology of recent advances in the crystallization and highresolution structural analysis of membrane proteins as well as in our understanding of the fundamental principles of the folding [76] and topology [77] of transmembrane proteins.
